anmelden
SLI
2.162,00
PKT
+10,82
PKT
+0,50
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.03.16 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 30.03.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 30.03.16 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 29.03.16 | Zurich Insurance overweight | Barclays Capital | |
| 29.03.16 | UBS overweight | Barclays Capital | |
| 29.03.16 | Swiss Re Equal weight | Barclays Capital | |
| 29.03.16 | Novartis Neutral | Citigroup Corp. | |
| 29.03.16 | Richemont buy | UBS AG | |
| 24.03.16 | UBS Halten | Independent Research GmbH | |
| 24.03.16 | UBS Equal-Weight | Morgan Stanley | |
| 24.03.16 | Richemont Neutral | Credit Suisse Group | |
| 24.03.16 | UBS buy | Goldman Sachs Group Inc. | |
| 24.03.16 | Holcim buy | Goldman Sachs Group Inc. | |
| 24.03.16 | UBS Neutral | UBS AG | |
| 23.03.16 | Holcim Neutral | BNP PARIBAS | |
| 23.03.16 | Roche buy | UBS AG | |
| 23.03.16 | Swiss Re buy | Deutsche Bank AG | |
| 22.03.16 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 22.03.16 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.03.16 | UBS Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.03.16 | Novartis buy | HSBC | |
| 22.03.16 | Roche Hold | HSBC | |
| 18.03.16 | Richemont overweight | Morgan Stanley | |
| 18.03.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 18.03.16 | Holcim neutral | Bernstein Research | |
| 18.03.16 | UBS Neutral | UBS AG | |
| 18.03.16 | Holcim buy | Deutsche Bank AG | |
| 18.03.16 | UBS Neutral | Nomura | |
| 18.03.16 | UBS buy | Nomura | |
| 18.03.16 | Swiss Re Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.16 | UBS buy | HSBC | |
| 17.03.16 | UBS buy | HSBC | |
| 16.03.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 16.03.16 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 16.03.16 | Richemont Outperform | BNP PARIBAS | |
| 16.03.16 | Richemont buy | UBS AG | |
| 15.03.16 | Roche buy | Jefferies & Company Inc. | |
| 14.03.16 | UBS overweight | Morgan Stanley | |
| 14.03.16 | UBS Equal-Weight | Morgan Stanley | |
| 14.03.16 | UBS buy | Citigroup Corp. |